Hyperoxia, HMGB1, and ventilator-associated pneumonia: reducing risk by practicing what we teach.
作者信息
Kennedy Thomas P, Nelson Steve
出版信息
Am J Respir Cell Mol Biol. 2013 Mar;48(3):269-70. doi: 10.1165/rcmb.2013-0020ED.
Abstract
摘要
相似文献
1
Hyperoxia, HMGB1, and ventilator-associated pneumonia: reducing risk by practicing what we teach.
Am J Respir Cell Mol Biol. 2013 Mar;48(3):269-70. doi: 10.1165/rcmb.2013-0020ED.
2
High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.
Am J Respir Cell Mol Biol. 2013 Mar;48(3):280-7. doi: 10.1165/rcmb.2012-0279OC. Epub 2012 Oct 18.
3
The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function.
Mol Med. 2014 Jun 19;20(1):238-47. doi: 10.2119/molmed.2013.00086.
4
Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia.
Am J Physiol Lung Cell Mol Physiol. 2013 Sep;305(5):L352-63. doi: 10.1152/ajplung.00387.2012. Epub 2013 Jun 21.
5
The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function.
Mol Med. 2020 Oct 30;26(1):98. doi: 10.1186/s10020-020-00224-9.
6
GAT107-mediated α7 nicotinic acetylcholine receptor signaling attenuates inflammatory lung injury and mortality in a mouse model of ventilator-associated pneumonia by alleviating macrophage mitochondrial oxidative stress via reducing MnSOD-S-glutathionylation.
Redox Biol. 2023 Apr;60:102614. doi: 10.1016/j.redox.2023.102614. Epub 2023 Jan 20.
7
Heat-shock response increases lung injury caused by Pseudomonas aeruginosa via an interleukin-10-dependent mechanism in mice.
Anesthesiology. 2014 Jun;120(6):1450-62. doi: 10.1097/ALN.0000000000000235.
8
Increased surfactant protein D fails to improve bacterial clearance and inflammation in serpinB1-/- mice.
Am J Respir Cell Mol Biol. 2012 Dec;47(6):792-9. doi: 10.1165/rcmb.2012-0145OC. Epub 2012 Sep 28.
9
MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection.
Sci Rep. 2021 Nov 22;11(1):22725. doi: 10.1038/s41598-021-02242-x.
10
Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
Mol Med. 2012 May 9;18(1):477-85. doi: 10.2119/molmed.2012.00024.
引用本文的文献
1
Glycyrrhizin Ameliorates Radiation Enteritis in Mice Accompanied by the Regulation of the HMGB1/TLR4 Pathway.
Evid Based Complement Alternat Med. 2020 May 31;2020:8653783. doi: 10.1155/2020/8653783. eCollection 2020.
2
The nitric oxide donor, (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NONOate/D-NO), increases survival by attenuating hyperoxia-compromised innate immunity in bacterial clearance in a mouse model of ventilator-associated pneumonia.
Biochem Pharmacol. 2020 Jun;176:113817. doi: 10.1016/j.bcp.2020.113817. Epub 2020 Jan 20.
本文引用的文献
1
High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.
Am J Respir Cell Mol Biol. 2013 Mar;48(3):280-7. doi: 10.1165/rcmb.2012-0279OC. Epub 2012 Oct 18.
2
Practice of excessive F(IO(2)) and effect on pulmonary outcomes in mechanically ventilated patients with acute lung injury.
Respir Care. 2012 Nov;57(11):1887-93. doi: 10.4187/respcare.01696. Epub 2012 May 15.
3
Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
Mol Med. 2012 May 9;18(1):477-85. doi: 10.2119/molmed.2012.00024.
4
Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU.
Curr Opin Infect Dis. 2011 Aug;24(4):385-9. doi: 10.1097/QCO.0b013e3283474914.
5
HMGB1 is a therapeutic target for sterile inflammation and infection.
Annu Rev Immunol. 2011;29:139-62. doi: 10.1146/annurev-immunol-030409-101323.
6
Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro.
Int Immunopharmacol. 2011 Feb;11(2):187-93. doi: 10.1016/j.intimp.2010.11.014. Epub 2010 Nov 21.
7
Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial.
Crit Care. 2010;14(5):R180. doi: 10.1186/cc9286. Epub 2010 Oct 11.
8
Clinicians' response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2.
Intensive Care Med. 2011 Jan;37(1):46-51. doi: 10.1007/s00134-010-2025-z. Epub 2010 Sep 28.
9
Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Am J Physiol Cell Physiol. 2010 Jul;299(1):C97-110. doi: 10.1152/ajpcell.00009.2010. Epub 2010 Apr 7.
10
Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness.
J Biol Chem. 2010 Feb 12;285(7):4995-5002. doi: 10.1074/jbc.M109.067454. Epub 2009 Dec 11.
Zotero 插件